Cancer: Out of air is not out of action
暂无分享,去创建一个
[1] G. V. Vande Woude,et al. HGF/SF‐met signaling in the control of branching morphogenesis and invasion , 2003, Journal of cellular biochemistry.
[2] Napoleone Ferrara,et al. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. , 2002, Seminars in oncology.
[3] P. Comoglio,et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. , 2003, Cancer cell.
[4] P Vaupel,et al. Biological consequences of tumor hypoxia. , 2001, Seminars in oncology.
[5] Toshikazu Nakamura,et al. Hepatocyte growth factor: from diagnosis to clinical applications. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[6] Richard D Klausner,et al. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. , 2002, Cancer cell.
[7] C. Birchmeier,et al. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.
[8] G. Michalopoulos,et al. Liver Regeneration , 1997, Science.
[9] L. Schmidt,et al. Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Jain. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.